Hepatic Injury following Reduced Intensity Unrelated Cord Blood Transplantation for Adult Patients with Hematological Diseases

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 12, 2006, Pages 1302-1309

  Kusumi, Eiji ^a,b   Kami, Masahiro ^b   Kanda, Yoshinobu ^c   Murashige, Naoko ^d   Seki, Kunihiko ^a   Fujiwara, Masayo ^a   Koyama, Rikako ^a   Komatsu, Tsunehiko ^e   Hori, Akiko ^b   Tanaka, Yuji ^b   Yuji, Koichiro ^b   Matsumura, Tomoko ^b   Masuoka, Kazuhiro ^a   Wake, Atsushi ^a   Miyakoshi, Shigesaburo ^a   Taniguchi, Shuichi ^a  

^a TORANOMON HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e Tsukuba Memorial Hospital   (Japan)

Author keywords

Allogeneic stem cell transplantation; Blood stream infection; Cholangitis lenta; Graft versus host disease

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; BILIRUBIN; BUSULFAN; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; FOSCARNET; GAMMA GLUTAMYLTRANSFERASE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; MICAFUNGIN; PURINE DERIVATIVE; TACROLIMUS; TOSUFLOXACIN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTEREMIA; CHOLANGITIS; CHOLESTASIS; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMORBIDITY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC DISEASE; HUMAN; HYPERBILIRUBINEMIA; IMAGE ANALYSIS; LABORATORY TEST; LIVER INJURY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; MYELODYSPLASIA; MYELOID METAPLASIA; MYELOMA; PATHOGENESIS; PNEUMOCYSTOSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; REDUCED INTENSITY CONDITIONING; REFRACTORY ANEMIA; RISK FACTOR; SEPSIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BUSULFAN; CHOLANGITIS; CORD BLOOD STEM CELL TRANSPLANTATION; CYCLOSPORINE; FEMALE; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HEPATIC VENO-OCCLUSIVE DISEASE; HEPATITIS, TOXIC; HUMANS; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT, NEWBORN; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MELPHALAN; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TACROLIMUS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 33845267429     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.07.013     Document Type: Article

References (38)

1. Strasser S., and McDonald G. Hepatobiliary complications of hematopoietic cell transplantation. In: Schiff E., Sorrell M., and Maddrey W. (Eds). Schiff's Diseases of the Liver (2003), Lippincott, Philadelphia 1636-1663
2. McDonald G.B., Sharma P., Matthews D.E., Shulman H.M., and Thomas E.D. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4 (1984) 116-122
3. McDonald G.B., Hinds M.S., Fisher L.D., et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118 (1993) 255-267
4. Kami M., Mori S., Tanikawa S., et al. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution. Bone Marrow Transplant 20 (1997) 397-402
5. Jones R.J., Lee K.S., Beschorner W.E., et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44 (1987) 778-783
6. Bearman S.I. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 85 (1995) 3005-3020
7. Hogan W.J., Maris M., Storer B., et al. Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. Blood 103 (2004) 78-84
8. Schetelig J., Kroger N., Held T.K., et al. Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease. Haematologica 87 (2002) 299-305
9. Shapira M.Y., Resnick I.B., Bitan M., et al. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. Bone Marrow Transplant 34 (2004) 155-159
10. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 (2001) 3390-3400
11. Mielcarek M., Martin P.J., Leisenring W., et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102 (2003) 756-762
12. Junghanss C., Marr K.A., Carter R.A., et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant 8 (2002) 512-520
13. Junghanss C., Boeckh M., Carter R.A., et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 99 (2002) 1978-1985
14. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
15. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
16. Takahashi S., Iseki T., Ooi J., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 104 (2004) 3813-3820
17. Tomonari A., Iseki T., Takahashi S., et al. Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol 122 (2003) 802-805
18. Tomonari A., Iseki T., Ooi J., et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br J Haematol 121 (2003) 304-311
19. Maeda T., Kusumi E., Kami M., et al. Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases. Bone Marrow Transplant 35 (2005) 91-97
20. Hamza N.S., Lisgaris M., Yadavalli G., et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 124 (2004) 488-498
21. Kishi Y., Miyakoshi S., Kami M., et al. Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant 10 (2004) 561-568
22. Kishi Y., Kami M., Miyakoshi S., et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 80 (2005) 34-40
23. Narimatsu H., Matsumura T., Kami M., et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 11 (2005) 429-436
24. Nishihira H., Kato K., Isoyama K., et al. The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis. Br J Haematol 120 (2003) 516-522
25. Nash R.A., Antin J.H., Karanes C., et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96 (2000) 2062-2068
26. Yee G.C., Self S.G., McGuire T.R., et al. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation. N Engl J Med 319 (1988) 65-70
27. Hiraoka A., Ohashi Y., Okamoto S., et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant 28 (2001) 181-185
28. Ratanatharathorn V., Nash R.A., Przepiorka D., et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92 (1998) 2303-2314
29. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
30. Hughes W.T., Armstrong D., Bodey G.P., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
31. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
32. Sakiyama M., Kami M., Hori A., et al. Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0. Bone Marrow Transplant 34 (2004) 787-794
33. Iwata H., Kami M., Hori A., et al. An autopsy-based retrospective study of secondary thrombotic thrombocytopenic purpura. Haematologica 86 (2001) 669-670
34. Bennett W.M., and Pulliam J.P. Cyclosporine nephrotoxicity. Ann Intern Med 99 (1983) 851-854
35. Arcese W., Rocha V., Labopin M., et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 91 (2006) 223-230
36. Chao N.J., Koh L.P., Long G.D., et al. Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 10 (2004) 569-575
37. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105 (2005) 1343-1347
38. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102 (2003) 1915-1919